However, studies conducted so far in AD with Omalizumab, an anti-IgE monoclonal antibody, indicated for chronic spontaneous urticaria (CSU), allergic asthma and chronic rhinosinusitis with nasal polyps (CRSwNP), have been found to be inconclusive [44,45]. The gene discussed is IGHE; the disease is Alzheimer disease.